Gemcitabine and Erlotinib in Treating Patients With Metastatic or Recurrent Pancreatic Cancer (UCDCC#211)

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of California, Davis Identifier:
First received: December 17, 2008
Last updated: August 18, 2014
Last verified: August 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)
No publications provided by University of California, Davis

Publications automatically indexed to this study by Identifier (NCT Number):